Harriet De Wit to Polymorphism, Genetic
This is a "connection" page, showing publications Harriet De Wit has written about Polymorphism, Genetic.
Connection Strength
0.823
-
Polymorphisms in dopamine transporter (SLC6A3) are associated with stimulant effects of D-amphetamine: an exploratory pharmacogenetic study using healthy volunteers. Behav Genet. 2010 Mar; 40(2):255-61.
Score: 0.264
-
Serotonin transporter genotype and acute subjective response to amphetamine. Am J Addict. 2006 Sep-Oct; 15(5):327-35.
Score: 0.209
-
Genetic factors modulating the response to stimulant drugs in humans. Curr Top Behav Neurosci. 2012; 12:537-77.
Score: 0.075
-
Genetics of caffeine consumption and responses to caffeine. Psychopharmacology (Berl). 2010 Aug; 211(3):245-57.
Score: 0.068
-
Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2008 Nov; 33(12):2791-800.
Score: 0.058
-
Association between the casein kinase 1 epsilon gene region and subjective response to D-amphetamine. Neuropsychopharmacology. 2006 May; 31(5):1056-63.
Score: 0.051
-
Biological and behavioral markers of alcohol sensitivity. Alcohol Clin Exp Res. 2004 Feb; 28(2):247-56.
Score: 0.044
-
Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology. 2003 Sep; 28(9):1694-702.
Score: 0.042
-
Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry. 2007 Jun 01; 61(11):1296-305.
Score: 0.013